LFB To Pay 95 million Euros!!! I found it quite amazing after doing some DD on this company. What I found remrkable are the following;
- LFD will pay TLN 95 million euro (more than $3 per share) for getting the licensing right for the product in some countries and TLN will retain the rights in North America and other regions.
- TLN also owns 16% of an Capricon an imaging and marker ID company
- share structure very tight at around 35 million shares
- No debt
- fully carried by LFD in the ongoing Phase II trials
- No known medication exists for the ECOLi treatment they are investigating
- Market cap less than 6 million.
This is looking too good to be true!!! Can someone in this game for a longer time tell me why the share price has remained depressed for the past 2 to 3 years because I am defintely missing something. Would be highly appreciated!